Sequana Medical Future Growth
Future criteria checks 2/6
Sequana Medical is forecast to grow earnings and revenue by 69% and 69.6% per annum respectively while EPS is expected to grow by 65.3% per annum.
Key information
69.0%
Earnings growth rate
65.3%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 69.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 23 | -6 | N/A | -5 | 1 |
12/31/2025 | 31 | -1 | N/A | -5 | 1 |
12/31/2024 | 1 | -21 | -35 | -24 | 2 |
12/31/2023 | 1 | -33 | -30 | -29 | N/A |
9/30/2023 | 1 | -32 | -30 | -30 | N/A |
6/30/2023 | 1 | -32 | -30 | -30 | N/A |
3/31/2023 | 1 | -32 | -29 | -29 | N/A |
12/31/2022 | 1 | -31 | -28 | -27 | N/A |
9/30/2022 | 1 | -29 | -27 | -26 | N/A |
6/30/2022 | 1 | -27 | -26 | -25 | N/A |
3/31/2022 | 1 | -25 | -25 | -25 | N/A |
12/31/2021 | 0 | -24 | -24 | -24 | N/A |
9/30/2021 | 0 | -23 | -22 | -22 | N/A |
6/30/2021 | 0 | -21 | -20 | -20 | N/A |
3/31/2021 | 1 | -20 | -18 | -18 | N/A |
12/31/2020 | 1 | -19 | -17 | -17 | N/A |
9/30/2020 | 1 | -18 | -16 | -16 | N/A |
6/30/2020 | 1 | -17 | -16 | -16 | N/A |
3/31/2020 | 1 | -16 | -17 | -17 | N/A |
12/31/2019 | 1 | -15 | -19 | -18 | N/A |
9/30/2019 | 1 | -16 | -19 | -19 | N/A |
6/30/2019 | 1 | -16 | -18 | -18 | N/A |
3/31/2019 | 1 | -15 | -14 | -14 | N/A |
12/31/2018 | 1 | -14 | -10 | -10 | N/A |
9/30/2018 | 1 | -10 | -8 | -8 | N/A |
12/31/2017 | 1 | -8 | -8 | -8 | N/A |
12/31/2016 | 1 | -14 | N/A | -13 | N/A |
12/31/2015 | 2 | -12 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2SE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2SE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2SE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2SE's revenue (69.6% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 2SE's revenue (69.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2SE's Return on Equity is forecast to be high in 3 years time